OncoMatch

OncoMatch/Clinical Trials/NCT07856017

Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making

Official title: An MRI-Based Diagnostic Model for Prostate Cancer Localization: An Exploratory Study Integrating Radiomics and the Metabolic Microenvironment

Is NCT07856017 recruiting? Yes, currently enrolling (Oct 2026).

RecruitingShanghai Zhongshan HospitalNCT07856017Data as of Oct 2026Location: China

Development of an Intelligent System Integrating Preoperative Imaging and Real-Time Intraoperative Metabolic Feedback to Dynamically Optimize Biopsy core Placement for Individualized Precision Sampling.

Check if I qualify

Extracted eligibility criteria

Cancer type

Prostate Cancer

Demographics

Ages ≥ 55
Male only

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07856017 currently recruiting?

Yes, this trial is currently recruiting patients.

Is this trial open to female patients?

No. This trial enrolls male patients only.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify